Ideaya Biosciences Stock Target Price and Analyst Consensus

IDYA Stock  USD 27.36  0.15  0.55%   
The current analyst and expert consensus on Ideaya Biosciences is Strong Buy, with 10 strong buy opinions. The current projected Ideaya Biosciences target price consensus is 47.06 with 13 analyst opinions. Check out Macroaxis Advice on Ideaya Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.
The most common way Ideaya Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Ideaya Biosciences executives and customers to further validate their buy or sell advice. Ideaya Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Ideaya Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 3.2731.
Lowest Forecast
42.82
Highest Forecast
52.24
Target Price
47.06
The current year's Gross Profit Margin is expected to grow to 0.78, whereas Gross Profit is forecasted to decline to about 6.7 M. At present, Ideaya Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 20.1 M, whereas Total Current Liabilities is forecasted to decline to about 28 M.
It's important to approach Ideaya Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Ideaya Biosciences Target Price Consensus

Ideaya target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Ideaya Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   13  Strong Buy
Most Ideaya analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Ideaya stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Ideaya Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Ideaya Biosciences Target Price Projection

Ideaya Biosciences' current and average target prices are 27.36 and 47.06, respectively. The current price of Ideaya Biosciences is the price at which Ideaya Biosciences is currently trading. On the other hand, Ideaya Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Ideaya Biosciences Market Quote on 2nd of October 2025

Low Price27.09Odds
High Price28.0Odds

27.36

Target Price

Analyst Consensus On Ideaya Biosciences Target Price

Low Estimate42.82Odds
High Estimate52.24Odds

47.0588

Historical Lowest Forecast  42.82 Target Price  47.06 Highest Forecast  52.24
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Ideaya Biosciences and the information provided on this page.

Ideaya Biosciences Analyst Ratings

Ideaya Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Ideaya Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Ideaya Biosciences' financials, market performance, and future outlook by experienced professionals. Ideaya Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Ideaya Biosciences price targets

Ideaya Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Ideaya Biosciences' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Ideaya Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ideaya Biosciences' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Ideaya Biosciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ideaya Biosciences is a key component of Ideaya Biosciences valuation and have some predictive power on the future returns of a Ideaya Biosciences.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ideaya Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
24.0827.3530.62
Details
Intrinsic
Valuation
LowRealHigh
24.6231.9135.18
Details
Naive
Forecast
LowNextHigh
24.7828.0531.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.92-0.78-0.24
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
Power Assets Idea
Power Assets
Invested over 90 shares
Basic Utilities Idea
Basic Utilities
Invested over 90 shares
Gold and Gold Mining Idea
Gold and Gold Mining
Invested few shares
Precious Metals Idea
Precious Metals
Invested few shares
Steel Works Etc Idea
Steel Works Etc
Invested few shares
Healthcare Idea
Healthcare
Invested few shares
Obamacare Idea
Obamacare
Invested few shares
Chemicals Idea
Chemicals
Invested few shares
Semiconductor Idea
Semiconductor
Invested few shares
When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:
Check out Macroaxis Advice on Ideaya Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Please note, the presentation of Ideaya Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ideaya Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ideaya Biosciences' management manipulating its earnings.